Annual Shareholders Equity
$4.85 M
-$2.85 M-37.03%
01 September 2023
Summary:
Bright Minds Biosciences annual stockholders equity is currently $4.85 million, with the most recent change of -$2.85 million (-37.03%) on 01 September 2023. During the last 3 years, it has fallen by -$10.36 million (-68.09%). DRUG annual shareholders equity is now -68.09% below its all-time high of $15.21 million, reached on 30 September 2021.DRUG Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$4.45 M
+$245.30 K+5.83%
01 June 2024
Summary:
Bright Minds Biosciences quarterly stockholders equity is currently $4.45 million, with the most recent change of +$245.30 thousand (+5.83%) on 01 June 2024. Over the past year, it has dropped by -$401.10 thousand (-8.26%). DRUG quarterly shareholders equity is now -77.81% below its all-time high of $20.07 million, reached on 31 March 2021.DRUG Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DRUG Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | -8.3% |
3 y3 years | -68.1% | -70.7% |
5 y5 years | - | - |
DRUG Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -68.1% | at low | -70.7% | +5.8% |
5 y | 5 years | -68.1% | +791.0% | -77.8% | +717.4% |
alltime | all time | -68.1% | +791.0% | -77.8% | +717.4% |
Bright Minds Biosciences Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
June 2024 | - | $4.45 M(+5.8%) |
Mar 2024 | - | $4.21 M(-7.5%) |
Dec 2023 | - | $4.55 M(-6.3%) |
Sept 2023 | $4.85 M(-37.0%) | $4.85 M(-16.7%) |
June 2023 | - | $5.83 M(-11.9%) |
Mar 2023 | - | $6.61 M(-18.1%) |
Dec 2022 | - | $8.08 M(+4.8%) |
Sept 2022 | $7.71 M | $7.71 M(+17.8%) |
June 2022 | - | $6.55 M(-24.1%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $8.62 M(-26.4%) |
Dec 2021 | - | $11.70 M(-23.1%) |
Sept 2021 | $15.21 M(+2692.0%) | - |
Sept 2021 | - | $15.21 M(-13.8%) |
June 2021 | - | $17.66 M(-12.0%) |
Mar 2021 | - | $20.07 M(+1125.3%) |
Dec 2020 | - | $1.64 M(+200.6%) |
Sept 2020 | $544.80 K | - |
Sept 2020 | - | $544.80 K |
FAQ
- What is Bright Minds Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly shareholders equity year-on-year change?
What is Bright Minds Biosciences annual stockholders equity?
The current annual shareholders equity of DRUG is $4.85 M
What is the all time high annual shareholders equity for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual stockholders equity is $15.21 M
What is Bright Minds Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of DRUG is $4.45 M
What is the all time high quarterly shareholders equity for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly stockholders equity is $20.07 M
What is Bright Minds Biosciences quarterly shareholders equity year-on-year change?
Over the past year, DRUG quarterly stockholders equity has changed by -$401.10 K (-8.26%)